Navigation Links
Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
Date:7/20/2011

ROCKVILLE, Md., July 20, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced it will release results for the second quarter of 2011, on Thursday, August 4, 2011, before the market opens. A full text copy of the release will be disseminated at that time.

Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results at 10:00 AM ET on Thursday, August 4, 2011.  Also participating on the call will be James Kelly, Senior Vice President and Chief Financial Officer.  To participate in the conference call, dial the appropriate number below shortly before the 10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.

The teleconference dial-in numbers are as follows:

Domestic callers 1-866-314-5232

International callers 1-617-213-8052

Participant Passcode 16117516

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Thursday, August 4, 2011, beginning at 1:00 PM ET and will be accessible until Thursday, August 11, 2011, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 57140859.

ABOUT VANDA PHARMACEUTICALS INC.:

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders.  For more on
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 With increasing clinical ... experiencing a rise in active partnerships. The primary ... nations to quantitate CD4 cell markers in human ... http://photos.prnewswire.com/prnh/20150831/262206LOGO New analysis ... Flow Cytometry Market ( http://www.frost.com/nf0e ), finds the ...
(Date:8/31/2015)...  On August 5, 2015, the U.S. District Court ... denied motions to dismiss securities class action claims against ... of its directors. The class actions allege that the ... to artificially inflate Galena,s stock price, and during an ... inflated, sold massive amounts of their personally-held shares. ...
(Date:8/31/2015)... , Aug. 31, 2015  Dipexium Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of Locilex® (pexiganan cream 0.8%), ... plans to participate in four investor conferences in September. ... at the Sidoti & Company, LLC Emerging Growth Conference ... David P. Luci , President & Chief Executive ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3
... Nov. 15, 2011 Reportlinker.com announces that ... in its catalogue: ... India & China ... emerging economies represent a combined pharmaceutical market ...
... Pa, Nov. 15, 2011 As any purchasing manager knows, ... shipping options is time lost. When purchasing surgical instruments ... In January of 2010, Robert Edelstein, President of Millennium ... Saints Charities seeking a vendor for eye surgical instruments ...
Cached Medicine Technology:The Outlook for Pharmaceuticals in Brazil, Russia, India & China 2The Outlook for Pharmaceuticals in Brazil, Russia, India & China 3The Outlook for Pharmaceuticals in Brazil, Russia, India & China 4The Outlook for Pharmaceuticals in Brazil, Russia, India & China 5Millennium Surgical Corp. Provides Instruments to Latter Day Saints Charities for Humanitarian Projects 2
(Date:8/31/2015)... ... August 31, 2015 , ... ... may be at a greater risk for injury, potentially because they are more ... of Pittsburgh Graduate School of Public Health analysis discovered. , The research, ...
(Date:8/31/2015)... York, NY (PRWEB) , ... August 31, 2015 ... ... simulations that enable users to develop skills and assess their competencies in managing ... of research, will present at the Defense Centers of Excellence for Psychological ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... On ... With A Mission” at the Adams County Fairgrounds in Mendon, IL. The purpose behind ... school districts of Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music ...
(Date:8/31/2015)... ... August 31, 2015 , ... The German soccer league (DFL ... (CMS) and make website updates quicker and more flexible. The company's CMS solution ... Bundesliga (the German equivalent of the U.S. Soccer Federation) more modern, exciting and ...
(Date:8/31/2015)... ... ... “My mother and husband use oxygen therapy and the tubing irritates the ... be a comfortable way to prevent the irritation, so I invented this.” She invented ... secure way to anchor the cannula tubing used in oxygen therapy and it prevents ...
Breaking Medicine News(10 mins):Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2
... Recent research has revealed that women aged 60 and ... heart attack compared to others. The results of the ... such patients when compared to heart attack patients who ... been published in the April 24 issue of the ...
... Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, ... Shipments of pravastatin sodium tablets// have been started ... mg strengths. ,Watson Pharmaceuticals, Inc. has ... leading specialty pharmaceutical company that specializes in the ...
... Pyszczynski, professor, Psychology, University of Colorado at Colorado ... Zarand, //Iran, Sheldon Solomon, professor, Psychology, Skidmore College, ... University of Arizona, Tuscon. , In ... were questioned and were found that thoughts of ...
... practice followed is to begin immunizations of babies at two ... not achieve// the desired purpose, due to the incapacity of ... the vaccines. Now, according to a new study conducted by ... response in newborns, with a certain type of molecule present ...
... Health Organization (WHO) is in the process of updating the ... the new one, which will present// the rates at which ... form. ,The 20-year old charts are said to ... revision is based on growth data from breast-fed babies who ...
... of two decades ago still holds more than a third ... here still continues// to cause cancer in children according to ... ,According to official measurements published in the report at least ... for centuries as a result of the disaster. ...
Cached Medicine News:Health News:Depression Accompanies Heart Attacks in Younger Women 2
... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
... These dual pressure sensor ... sampling/slow-speed injection, slow-speed injection/guide wire, ... model SPC-784A for high-speed injection ... side openings and an open-end ...
... These dual pressure sensor catheters ... injection, slow-speed injection/guide wire, or ... SPC-784A for high-speed injection has ... openings and an open-end pigtail ...
... Dual Pressure Sensor Intravascular Mikro-Tip ... a line of dual pressure sensor ... measurements. These catheters are suitable for ... between chambers, or across a vascular ...
Medicine Products: